Salute e Benessere

Nonwoven Filtration Market is Forecast to Reach US$ 8.4 Billion in 2028, Says…

Click here for a free sample pdf: https://www.stratviewresearch.com/Request-Sample/3455/nonwoven-filtration-market.html#form Click here for a free sample pdf: https://www.stratviewresearch.com/Request-Sample/3455/nonwoven-filtration-market.html#form Report Highlights Segment Insights on Nonwoven Filtration Market The nonwoven filtration market is segmented based onapplication type, web-formation type, material type, and region. Based on application type -...

Mithra to hold five presentations on key role of estrogens in women's health…

Mithra to hold five presentations on key role of estrogens in women's health, including Estetrol (E4), at the ESG Congress in AmsterdamFive abstracts on the positive effect of E4 accepted for oral presentationEleven leading experts to outline why estrogen is critical in contraception and for the treatment of postmenopausal symptomsData show promising efficacy and safety features of E4, key ingredient in ESTELLE® and DONESTA®Liege, Belgium, 28 November 2023 – 17:45 CET...

CHARAC SECURES £1M INVESTMENT FROM WORLD-CLASS MEDICATION PLATFORM MEDADVISOR TO…

LONDON, Nov. 28, 2023 /PRNewswire/ -- Leading healthcare SaaS provider Charac today announces a ground-breaking partnership with world-class medication management platform MedAdvisor Solutions (ASX:MDR). The deal with Australia-based MedAdvisor allows Charac to expand it capabilities across Australia, New Zealand and the USA, making components of its app available to a far broader group of pharmacies internationally. LONDON , Nov. 28, 2023 /PRNewswire/ -- Leading healthcare SaaS provider...

Global eHealth Market Set to Hit $272.54 Bn by 2030, Growing at 14.84% CAGR…

Request Sample PDF of the Report: https://www.kingsresearch.com/request-sample/ehealth-market-291 Request Sample PDF of the Report:https://www.kingsresearch.com/request-sample/ehealth-market-291 Electronic health, or eHealth, is the application of digital, and information & communication technologies (ICT) to enhance the management, delivery, and results of healthcare. It includes a broad spectrum of applications designed to improve healthcare offerings. Electronic health records...

Respiratory Diagnostics Market Worth $8.2 Billion | MarketsandMarkets

Browse in-depth TOC on "Respiratory Diagnostics Market" 83 - Tables 45 - Figures 146 - Pages Browse in-depth TOC on "Respiratory Diagnostics Market"83 - Tables45 - Figures146 - Pages Respiratory Diagnostics Market Scope: "Instruments and Devices segment accounted for the largest share and is expected to grow at the highest rate during the forecast period." The growing trend towards point-of-care testing (POCT) represents a paradigm shift in healthcare,...

Psychedelic Drugs Market to Reach $2,614.1 Million, by 2032 at 13.4% CAGR…

Request Sample of the Report on Psychedelic Drugs Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/12433 Request Sample of the Report on Psychedelic Drugs Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/12433 Prime determinants of growth The psychedelic drugs market has experienced significant growth due to surge in prevalence of the mental health crises, rise in the research and development of psychedelics to evaluate the...

Accorto Regulatory Solutions and Inter Scientific Enter Strategic Alliance to…

Inter Scientific co-founder David Lawson said, "We are thrilled to unveil our strategic alliance with Accorto. This collaboration represents a significant milestone, offering both new and existing clients a competitive advantage. By aligning with another industry-leading regulatory company that shares the same commitments to quality, urgency, and value, we are confident this will further elevate our standards and capacity." Inter Scientific co-founderDavid Lawsonsaid, "We are…

Bahrain, First in the Middle East to Acquire Latest Machine used for Human…

For her part, the Minister of Health, Dr. Jaleela bint Al-Sayed Jawad Hassan noted that acquiring this device is in line with continuing efforts to keep abreast of latest technological trends in the health field, while further developing the National Genome Centre, which will reflect positively on the various diagnostic and therapeutic services in place for the benefit of the community. For her part, the Minister of Health, Dr. Jaleela bintAl-Sayed Jawad Hassannoted that acquiring this...

Philips launches ultra lightweight and flexible MR Smart Fit coils to improve…

Amsterdam, the Netherlands and Chicago, USA –RoyalPhilips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today launched three new fit for purpose MR Smart Fit coils at #RSNA23 . RF coils are an essential part of every MRI scan. The new ultra-light weight coils provide exceptional flexibility, significant reduction in patient setup time and optimization with Philips' SmartSpeed AI solution, which allows for better image quality resolution and improved diagnostic...

Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer…

Proof of Concept –Evaxion's AI-Immunology™ platform demonstrates success in designing precision cancer vaccines in hematological cancers by targeting a novel class of antigens Broad Applicability –The vaccine concept holds tremendous potential, offering broad applicability and promising benefits for patients with hematological malignanciesCOPENHAGEN, Denmark, Nov.28, 2023(GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage...

UMKM EXPO(RT) BRILIANPRENEUR 2023 Paves the Way for Global Success for 700…

The event will kick off with virtual business matching sessions from 27-29 November, connecting buyers with selected MSME participants. Interested buyers can register at www.brilianpreneur.com. The event will kick off with virtual business matching sessions from 27-29 November, connecting buyers with selected MSME participants. Interested buyers can register atwww.brilianpreneur.com. Last year's UMKM EXPO(RT) BRILIANPRENEUR successfully attracted 43 buyers from 19 countries, generating...

Clario's New AI-Powered ECG Quality Score Tool Enhances Cardiac Safety…

Ellen Street, Executive Vice President, Cardiac Safety at Clario, expressed the company's enthusiasm, stating, "Clario's ECG Quality Score tool embodies our unwavering commitment to advancing trials and technologies through the use of AI/ML. We aim to provide sponsors with better insights into cardiac safety earlier in the drug development process and equip them with the tools needed to make informed decisions and collect higher quality data." Ellen Street, Executive Vice President…

Rising Prevalence of Obesity and Disability Conditions Globally Projected to…

NEWARK, Del., Nov. 28, 2023 /PRNewswire/ -- The global digital scale market is estimated to be US$564.6 million in 2024 and is projected to exhibit a CAGR of 4.5% over the forecast period. By 2034, the market is likely to cross a valuation of US$ 877.1 million. NEWARK, Del.,Nov. 28, 2023/PRNewswire/ -- The global digital scale market is estimated to beUS$564.6 million in 2024and is projected to exhibit a CAGR of4.5%over the forecast period. By 2034, the market is likely to...

Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194…

Novavax's vaccine can be stored at 2 to 8 degrees Celsius and has a 12-month shelf life, simplifying delivery, decreasing the carbon footprint and reducing wastage.1-4 Novavax's vaccine can be stored at 2 to 8 degrees Celsius and has a 12-month shelf life, simplifying delivery, decreasing the carbon footprint and reducing wastage. 1-4 The EUL was based on non-clinical data showing that Novavax's COVID-19 vaccine induced functional immune responses against XBB.1.5, XBB.1.16 and XBB.2...

Highly experienced CDMO expert Michel Spagnol appointed Chairman of Astraveus

Jérémie Laurent, Founder and Chief Executive Officer of Astraveus, said: "Michel's leadership will be instrumental as we look to accelerate the development and commercialization of our Lakhesys platform. We believe our microfluidic cell foundries will transform cell and gene therapy manufacturing, and Michel's expertise and track record will help us to successfully bring the benefits of these therapies to patients. We look forward to welcoming and working with him at Astraveus."…

Prime Acquires Aventine Consulting to Bolster US Evidence and Access Presence

Market access and payer engagement is one of the fastest growing areas in the pharmaceutical services sector (~13% market CAGR) and Aventine becomes Prime's first US acquisition. The move is set to significantly bolster and complement Prime's existing evidence and access proposition. As a result, the evidence and access function will include a US market access presence to geographically support US-based global clients. In addition, this newly expanded collaborative team will be perfectly…

IDTechEx Explores Hyper Personalized Approaches to Healthcare

Comfortable monitors Wearing a smartwatch does not take a second thought, so remembering to check blood pressure will not either. Smartwatches are now being cleverly designed with built-in sensitive sensors to keep on top of any abnormalities in heart rate, heart rhythm, and, in the future, blood pressure. People could soon go about daily activities such as watching TV while being monitored for high blood pressure, giving far more accurate results than just a few minutes in a...

Orexo announces FDA acceptance of New Drug Application filing for OX124, a…

Driven by the need to increase access to overdose medication, low-dose products, including the market leader, have recently been approved by the FDA as non-prescription over-the-counter (OTC) products. Historically, OTC products in the US have had limited reimbursement from insurance companies and, when applying similar industry analogues going forward, this may provide an advantage to high-dose prescription naloxone products, such as OX124. In addition, high-dose prescription products are…

RoslinCT to manufacture exagamglogene autotemcel (exa-cel) for Vertex…

RoslinCT to manufacture exagamglogene autotemcel (exa-cel) for Vertex Pharmaceuticals Inc following an extensive development collaborationRoslinCT will manufacture world's-first CRISPR-based therapyEDINBURGH, UK, 28 November 2023– RoslinCT, a cell and gene therapy Contract Development and Manufacturing Organisation ('CDMO') dedicated to developing therapies for patients who live with serious and life-threatening diseases, announces that it will manufacture the world's first...

Crossject announces initiation of coverage by ODDO BHF

Rated “Outperform” with price target of €7.10Analysts cite $60 million BARDA contract for Crossject's ZEPIZURE ®as validation of platform Dijon, France November 28, 2023, 07:30 CET -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company developing needle-free auto-injectors for emergency situations,announces initiation of coverage of its stock by analysts at independent financial group ODDO BHF.The ODDO BHF analysts rated Crossject as “Outperform” with a price...

Ultimovacs Announces Resignation of Aitana Peire from Board of Directors

Oslo, November 28, 2023:Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, today announces that Aitana Peire, Ph.D., has notified the Chair of the Board of Directors that she will resign as a board member due to her recent appointment as Director of Investments at The Johns Hopkins University. Aitana Peire has held the position as Investment Director of Canica's Future of Health assets and served as a member...

Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational…

Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational Progress on December 6, 2023 Halle (Saale) / Munich, Germany, November 28, 2023- Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced that it will publish its third quarter financial results...

Novartis upgrades mid-term sales growth guidance, showcases its differentiated…

Ad hoc announcement pursuant to Art. 53 LR 'Pure-play' innovative medicines strategy focused on four therapeutic areas and five technology platforms, which offer potential for consistent growthMid-term sales guidance upgrade to 5% CAGR (2022-27), with core operating income margin of ~40%+ by 2027, driven by continued strong momentum of key growth drivers Confidence to grow mid-single digit longer-term based on the foundational strength of de-risked existing brands and...

Addex Convenes Extraordinary General Meeting

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, November 28, 2023- Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that an Extraordinary General Meeting is convened and will take place on Tuesday December 19, 2023, at 11:00 am CET at the Campus Biotech, Chemin des Mines 9, 1202 Geneva (doors open at 10:30 am).The items in the agenda will be...

Altri Comunicati